Blood Transfusion: Procedure, Types, and Side Effects

A blood transfusion is one of the most common hospital procedures in the United States, where roughly 11 million units of red cells are transfused every year.¹ It means receiving donated blood — or, far more often, a single component of it — through an intravenous (IV) line, to replace what illness, surgery, or bleeding has taken away. Modern transfusion is also remarkably safe: every unit is typed, screened for infectious agents, and matched to the recipient before it ever reaches the bedside. This guide explains, plainly, what a transfusion is, the components you might receive, why it's done, exactly how the procedure works and how long it takes, the type-and-crossmatch steps that protect you, and the side effects and risks worth knowing — from the common and mild to the rare and serious. It sits within our blood type hub, and the interpretation of your own situation always belongs to your clinician.

Key takeaways

• A transfusion usually delivers a single component — most often packed red blood cells — not "whole blood." Platelets, plasma, and cryoprecipitate are given when those specific parts are needed.²³
• Before red cells are given, the lab performs ABO/Rh typing, an antibody screen, and a crossmatch, and a nurse does a final patient-identity check at the bedside — the last barrier against a mismatch.⁴⁵
• A unit of red cells typically infuses over 1 to 3 hours (never more than 4 hours per unit); platelets and plasma run faster.⁴⁶
• Most side effects are mild — allergic hives or a febrile non-hemolytic reaction. Serious events (TACO, TRALI, acute hemolytic reaction) are rare.⁷⁸
• The U.S. blood supply is very safe: every donation is screened for multiple infectious agents, making transfusion-transmitted infection extremely uncommon.¹
• Evidence supports a restrictive strategy — transfusing only when hemoglobin falls to about 7 g/dL — which is as safe as transfusing earlier in most stable patients.⁹¹⁰

What is a blood transfusion?

A blood transfusion is a procedure that puts donated blood or a blood component into your bloodstream through an IV line, usually in a vein in your arm.² It restores something your body is missing: red cells to carry oxygen, platelets or plasma to help blood clot, or specific clotting proteins. Donated blood comes from volunteers and is processed by blood centers such as the American Red Cross, then stored until a hospital needs it.³

The key idea in modern medicine is component therapy. Whole blood collected from a donor is separated into its parts, and a patient receives only the part they lack.³ Someone with anemia gets red cells; someone whose platelet count is dangerously low gets platelets. This makes each donation stretch further — one donation can help several patients — and spares you from receiving components you don't need. Whole blood itself is now used mainly in massive trauma resuscitation.

Transfusions happen in a controlled setting — a hospital, infusion center, or clinic — never routinely at home, precisely because the first minutes need close monitoring.⁴

The blood components

Blood is a mix of cells and fluid, and each part is transfused for a different reason:³²

• Packed red blood cells (PRBCs). Red cells with most of the plasma removed. By far the most transfused component, given to treat significant anemia or replace blood lost to bleeding. One unit typically raises an adult's hemoglobin by about 1 g/dL.
• Platelets. Tiny cell fragments that plug damaged vessels. Given when the platelet count is very low or platelets don't work — common in leukemia, chemotherapy, and bone-marrow disorders — to prevent or stop bleeding.
• Plasma (FFP). The liquid part of blood, rich in clotting factors. Transfused to correct bleeding when several clotting proteins are deficient, such as in liver disease or after large blood loss.
• Cryoprecipitate ("cryo"). A concentrate made from plasma, rich in fibrinogen and other clotting factors. Used to replace low fibrinogen in major bleeding or specific bleeding disorders.

Which component you receive — and how much — depends entirely on what your body is short of, confirmed by lab tests like a complete blood count and coagulation studies.

Why transfusions are done

Transfusions address three broad problems:²⁶

• Anemia that is severe or poorly tolerated — from chronic illness, cancer and chemotherapy, kidney disease, bone-marrow failure, or inherited disorders such as sickle cell disease and thalassemia.
• Acute bleeding — from major surgery, childbirth, or traumatic injury. Rapid, large-volume replacement is called massive transfusion.
• A specific deficiency — low or dysfunctional platelets (bleeding risk), or missing clotting factors corrected with plasma or cryoprecipitate.

The decision is never made on a single number. Your clinician weighs your hemoglobin level, your symptoms, how well you're tolerating the anemia, and the underlying cause before recommending a transfusion.⁹

The procedure (step by step, how long)

Transfusion follows a standardized sequence built entirely around safety:⁴⁵

1. Blood sample and lab work. A sample is drawn to determine your ABO and Rh type, run an antibody screen, and perform a crossmatch against the specific units to be given.
2. Consent and IV placement. Your care team explains the reason, benefits, and risks, and an IV line is started (or an existing one used).
3. Bedside identity check. Just before hanging the unit, two staff members verify your name and identification band against the label on the blood bag. This final check is the single most important step against a mismatch.⁵
4. The infusion. The unit runs in slowly at first while your vital signs — temperature, pulse, blood pressure — are recorded before starting, after the first 15 minutes, and periodically after. Most reactions appear early, so these opening minutes get the closest attention.
5. Completion and observation. When the unit finishes, you're monitored a while longer. Unless you need further treatment, you can usually go home the same day.⁴

How long does it take? A single unit of red cells typically infuses over 1 to 3 hours, and by rule must be completed within 4 hours of leaving controlled storage, for microbiological safety.⁴⁶ Platelets and plasma run faster — often 30 to 60 minutes each. Adding the lab work, consent, and monitoring, a visit for one or two units often occupies a half-day.

There is no fixed lifetime limit on how many transfusions a person can receive — the need is driven by the clinical situation. Patients transfused repeatedly over years (for example, in thalassemia) are monitored for iron overload, tracked with a ferritin test, because each unit adds iron the body cannot readily excrete.⁸

Safety: typing, crossmatch, and testing

Two independent systems make transfusion safe: matching the blood to you, and screening the blood itself.

Matching (type and crossmatch). Red cells carry surface antigens — chiefly the ABO and Rh systems — and giving ABO-incompatible red cells can trigger a life-threatening reaction. So the lab first determines your type, then runs an antibody screen to detect other red-cell antibodies you may have formed (from prior transfusion or pregnancy), and finally performs a crossmatch, physically testing donor cells against your plasma for compatibility.⁵ Group O red cells are the universal donor type used in emergencies before your own type is known, while AB individuals are universal red-cell recipients — the full logic is laid out in our blood type compatibility guide.

Screening the supply. Every U.S. donation is tested for multiple infectious agents — including HIV, hepatitis B and C, syphilis, West Nile virus, and others — and any unit that isn't clearly negative is discarded.¹ Donors are also screened by health history before they ever give, and the FDA inspects blood facilities and sets the standards that make transfusion-transmitted infection extremely rare today.¹³ These layered checks are why the modern blood supply is considered one of the safest in the world.

Side effects and risks

Thanks to careful matching, screening, and monitoring, transfusion is very safe — but reactions do happen. Most are mild; the serious ones are rare and actively guarded against.⁷⁸

• Allergic reactions. Usually mild — hives, itching — caused by proteins in the donor plasma. Easily treated; severe anaphylaxis is uncommon.
• Febrile non-hemolytic reaction. A fever and chills during or shortly after transfusion, from the recipient reacting to donor white cells or cytokines. Uncomfortable but not dangerous, and reduced by leukoreduced (white-cell-filtered) blood.
• Transfusion-associated circulatory overload (TACO). Fluid overload from transfusing too much or too fast, especially in older patients or those with heart or kidney disease — causing shortness of breath. Prevented by slow, monitored infusion.
• Transfusion-related acute lung injury (TRALI). A rare but serious reaction causing sudden breathing difficulty from lung inflammation; it is a leading cause of transfusion-related death and has been reduced by changes in plasma-donor selection.⁸
• Acute hemolytic reaction. The most feared complication, almost always from an ABO mismatch due to a clerical or identification error. The recipient's antibodies rapidly destroy the transfused red cells, which can be fatal. This is exactly what the repeated typing and bedside identity checks exist to prevent — which is why it is now rare.⁷
• Infection. Extremely low in countries with universal donor screening.¹

Warning signs — fever, chills, back or chest pain, shortness of breath, hives, or a feeling that something is wrong — should be reported immediately so the transfusion can be stopped. The point of close monitoring is to catch a reaction early.⁴

How much blood is transfused (the restrictive threshold)

For decades, doctors transfused fairly liberally. That has changed. A large body of evidence now supports a restrictive approach: for most stable hospitalized patients, waiting until hemoglobin drops to about 7 g/dL (or ~8 g/dL in some cardiac and orthopedic settings) is as safe as transfusing earlier — with no increase in death or complications, and less exposure to donor blood.⁹

This shift traces back to the landmark TRICC trial in critically ill patients, which found a restrictive threshold (transfuse below 7 g/dL) at least as good as a liberal one (below 10 g/dL), and possibly better in younger and less severely ill patients.¹⁰ A comprehensive 2025 Cochrane review — pooling more than 60 trials and over 27,000 patients — confirmed that restrictive strategies do not increase mortality across most clinical contexts, with a few exceptions (such as active cardiac ischemia or brain injury) where clinicians may transfuse sooner.⁹ The practical message: fewer transfusions, given only when truly needed, is usually the safer path — though the threshold is always individualized by the treating physician.

Frequently asked questions

Bottom line

A blood transfusion replaces what your body is missing — most often packed red blood cells, sometimes platelets, plasma, or cryoprecipitate — through a carefully controlled IV procedure. Its safety rests on two pillars: matching the blood to you (ABO/Rh typing, antibody screen, crossmatch, and a bedside identity check) and screening every donation for infection. A unit of red cells runs over 1 to 3 hours, and most side effects are mild, with serious reactions rare. Current practice favors a restrictive threshold — transfusing around 7 g/dL — which is as safe as transfusing earlier for most patients. To go deeper, see blood type compatibility, the universal blood donor, how blood donation works, and the blood type hub.

Sources

Official U.S. health authorities and peer-reviewed research (PubMed) used for this guide: